Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Parexel Intl Cp (PRXL) NASDAQ

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
3-Month Performance
View Chart

Fundamentals

See More
  • Market Capitalization, $K 3,736,680
  • Shares Outstanding, K 53,410
  • Annual Sales, $ 2,426 M
  • Annual Income, $ 155 M
  • 36-Month Beta 0.89
  • Price/Sales 1.54
  • Price/Book 5.43

Price Performance

See More
Period Period Low Period High Performance
1-Month
64.22 +8.19%
on 12/29/16
72.32 -3.93%
on 01/13/17
+4.86 (+7.52%)
since 12/23/16
3-Month
51.16 +35.81%
on 11/11/16
72.32 -3.93%
on 01/13/17
+1.88 (+2.78%)
since 10/24/16
52-Week
51.16 +35.81%
on 11/11/16
72.32 -3.93%
on 01/13/17
+4.42 (+6.79%)
since 01/22/16

Most Recent Stories

More News
Research Reports Initiation on Healthcare Stocks -- PAREXEL, Charles River Laboratories, PRA Health Sciences, and Invitae

Operators in the Medical Laboratories and Research industry provide analytic services to identify or determine the nature and cause of a disease or injury, through the evaluation of a patient's history,...

NVTA : 8.76 (-3.42%)
PRXL : 69.56 (+0.39%)
CRL : 79.51 (+0.11%)
PRAH : 54.51 (+0.04%)
PAREXEL International to Present at JP Morgan Healthcare Conference

PAREXEL International Corporation (NASDAQ: PRXL) announced today that it will be presenting at the JP Morgan Healthcare Conference on Tuesday, January 10, 2017, in San Francisco. Josef von...

PRXL : 69.56 (+0.39%)
Boston Millennia Partners Invests in Cota, Inc.

Boston Millennia Partners is pleased to announce its investment in Cota, Inc. as part of an $18 million growth equity round. Cota is a New York City based cancer outcomes and data...

CERN : 51.12 (+0.65%)
FMI : 18.55 (+0.27%)
PRXL : 69.56 (+0.39%)
YHOO : 43.86 (+3.44%)
MRK : 61.16 (-1.05%)
NVS : 69.96 (-0.26%)
CELGZ : 1.05 (+0.96%)
ACIW : 19.72 (+1.91%)
NTT : 44.29 (+0.05%)
Medical Laboratories & Research Stocks on Investors' Radar -- Quintiles IMS, PAREXEL, Charles River Laboratories, and PRA Health Sciences

Stock-Callers.com monitors the performances of these Medical Laboratories and Research equities at the last close: Quintiles IMS Holdings Inc. (NYSE: Q), PAREXEL International Corp. (NASDAQ: PRXL), Charles...

Q : 75.01 (-1.11%)
PRXL : 69.56 (+0.39%)
CRL : 79.51 (+0.11%)
PRAH : 54.51 (+0.04%)
PRXL Crosses Above Average Analyst Target

In recent trading, shares of PAREXEL International Corp. have crossed above the average analyst 12-month target price of $63.44, changing hands for $63.88/share.

PRXL : 69.56 (+0.39%)
PAREXEL International to Participate in Evercore ISI MedTools Conference

PAREXEL International Corporation (NASDAQ: PRXL) announced today that it will be attending the Evercore ISI MedTools Conference in Boston. Josef von Rickenbach, Chairman and Chief Executive...

PRXL : 69.56 (+0.39%)
EQUITY ALERT: Lundin Law PC Announces an Investigation of PAREXEL International Corporation and Advises Investors with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / November 14, 2016 / Lundin Law PC, a shareholder rights firm, announces that it is investigating claims against PAREXEL International Corporation ("PAREXEL" or the "Company")...

PRXL : 69.56 (+0.39%)
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Violations of Federal Securities Laws by Certain Officers and Directors of PAREXEL International Corporation

Levi & Korsinsky announces it has commenced an investigation of PAREXEL International Corporation (NASDAQ: PRXL) ("PAREXEL") concerning possible violations of federal securities laws by the...

PRXL : 69.56 (+0.39%)
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of PAREXEL International Corporation (PRXL)

Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of the securities of PAREXEL International Corporation ("PAREXEL" or the "Company") (NASDAQ:...

PRXL : 69.56 (+0.39%)
PAREXEL Launches IDMP-Focused Software and Service Solution

PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today launched an Identification of Medicinal Products (IDMP)-focused solution for...

PRXL : 69.56 (+0.39%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 16% Buy with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak.

See More

Business Summary

Parexel International Corporation is one of the largest biopharmaceutical outsourcing organizations in the world, providing a broad range of knowledge-based contract research, medical marketing and consulting services to the worldwide pharmaceutical, biotechnology and medical device industries. With...

See More

Support & Resistance

2nd Resistance Point 71.36
1st Resistance Point 70.33
Last Price 69.56
1st Support Level 68.68
2nd Support Level 68.06

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.